mhurhangee/patent-ind-claim-en huggingface dataset:
A system for treating a patient having a blood glucose abnormality, comprising: one or more processors ; a signal delivery device implantable in the epidural space of the patient's spinal cord region; a pulse generator electrically coupleable to the signal delivery device; a patient sensor ; and a machine-readable medium operatively coupled to the patient sensor and the pulse generator, the machine-readable medium having machine-readable instructions that, when executed, cause said one or more processors to: receive an input from the patient sensor corresponding to a patient neural signal and/or a patient neural response; determine a blood glucose level of the patient based on the patient neural signal and/or the patient neural response; and in response to the determined blood glucose level, change at least one parameter in accordance with which the pulse generator directs an electrical signal to the implantable signal delivery device, wherein the electrical signal has a frequency in a frequency range of from 1.2 kHz to 100 kHz. a signal delivery device implantable in the epidural space of the patient's spinal cord region; a pulse generator electrically coupleable to the signal delivery device; a patient sensor ; and a machine-readable medium operatively coupled to the patient sensor and the pulse generator, the machine-readable medium having machine-readable instructions that, when executed, cause said one or more processors to: receive an input from the patient sensor corresponding to a patient neural signal and/or a patient neural response; determine a blood glucose level of the patient based on the patient neural signal and/or the patient neural response; and in response to the determined blood glucose level, change at least one parameter in accordance with which the pulse generator directs an electrical signal to the implantable signal delivery device, wherein the electrical signal has a frequency in a frequency range of from 1.2 kHz to 100 kHz. receive an input from the patient sensor corresponding to a patient neural signal and/or a patient neural response; determine a blood glucose level of the patient based on the patient neural signal and/or the patient neural response; and in response to the determined blood glucose level, change at least one parameter in accordance with which the pulse generator directs an electrical signal to the implantable signal delivery device, wherein the electrical signal has a frequency in a frequency range of from 1.2 kHz to 100 kHz.
An electroacoustic transducer , comprising: a diaphragm ; a frame that is disposed around the diaphragm so as to surround the diaphragm; an edge that closes a space between the diaphragm and the frame in a manner of forming a membrane so as to connect the diaphragm and the frame to each other; a base body that supports the frame and has a through sound output hole in front of the diaphragm; a magnet that is attached to the frame ; and a voice coil body that is attached to the diaphragm , wherein the frame has an annular first fitting portion that is disposed around the diaphragm so as to surround the diaphragm , the first fitting portion being an annular projection projecting toward the base body , the base body has a second fitting portion that fits with the first fitting portion , the second fitting portion being an annular groove that opens toward the frame , and the electroacoustic transducer further comprises a sealing member that is made of a thermoplastic substance and seals a space between the first fitting portion and the second fitting portion fitted with each other. a diaphragm ; a frame that is disposed around the diaphragm so as to surround the diaphragm; an edge that closes a space between the diaphragm and the frame in a manner of forming a membrane so as to connect the diaphragm and the frame to each other; a base body that supports the frame and has a through sound output hole in front of the diaphragm; a magnet that is attached to the frame ; and a voice coil body that is attached to the diaphragm , wherein the frame has an annular first fitting portion that is disposed around the diaphragm so as to surround the diaphragm , the first fitting portion being an annular projection projecting toward the base body , the base body has a second fitting portion that fits with the first fitting portion , the second fitting portion being an annular groove that opens toward the frame , and the electroacoustic transducer further comprises a sealing member that is made of a thermoplastic substance and seals a space between the first fitting portion and the second fitting portion fitted with each other.
Immunoassay method for an antibody specific for an antigen of a virus of the Capripoxvirus genus, in a biological sample comprising the following steps: (i) Contacting at least one primary antigen comprising at least one synthetic or recombinant rP32 protein or an antigenic peptide fragment thereof, with a biological sample suspected of containing said antibody specific for said primary antigen, under conditions allowing the formation of a 'primary antigen/antibody' complex; (ii) Addition of at least one conjugate containing at least one secondary antigen comprising a synthetic or recombinant rP32 protein or an antigenic peptide fragment thereof and a marker under conditions allowing the formation of a 'primary antigen/antibody/conjugate' complex; and (iii) Detection of said primary antigen/antibody/conjugate complex. (i) Contacting at least one primary antigen comprising at least one synthetic or recombinant rP32 protein or an antigenic peptide fragment thereof, with a biological sample suspected of containing said antibody specific for said primary antigen, under conditions allowing the formation of a 'primary antigen/antibody' complex; (ii) Addition of at least one conjugate containing at least one secondary antigen comprising a synthetic or recombinant rP32 protein or an antigenic peptide fragment thereof and a marker under conditions allowing the formation of a 'primary antigen/antibody/conjugate' complex; and (iii) Detection of said primary antigen/antibody/conjugate complex.
A laser recording device , comprising: a conveyance mechanism configured to feed a thermal medium , the thermal medium comprising: a photothermal conversion layer that converts an applied laser beam into heat; a color development layer that develops a color by the heat converted by the photothermal conversion layer ; and characterised in that the laser recording device further comprises a storage mechanism that stores information related to a medium parameter including a photothermal conversion efficiency of the photothermal conversion layer ; a laser irradiation mechanism configured to irradiate the thermal medium with a laser beam; a reading mechanism configured to read the medium parameter; a processor configured to set an irradiation parameter related to laser beam irradiation based on the medium parameter, and irradiate the thermal medium with the laser beam using the laser irradiation mechanism in accordance with the set irradiation parameter; and a camera configured to capture an image of the thermal medium , the processor being configured to: print a chart on the thermal medium using the laser irradiation mechanism ; capture an image including the chart using the camera ; and correct the irradiation parameter using the image. a conveyance mechanism configured to feed a thermal medium , the thermal medium comprising: a photothermal conversion layer that converts an applied laser beam into heat; a color development layer that develops a color by the heat converted by the photothermal conversion layer ; and characterised in that the laser recording device further comprises a storage mechanism that stores information related to a medium parameter including a photothermal conversion efficiency of the photothermal conversion layer ; a laser irradiation mechanism configured to irradiate the thermal medium with a laser beam; a reading mechanism configured to read the medium parameter; a processor configured to set an irradiation parameter related to laser beam irradiation based on the medium parameter, and irradiate the thermal medium with the laser beam using the laser irradiation mechanism in accordance with the set irradiation parameter; and a camera configured to capture an image of the thermal medium , the processor being configured to: print a chart on the thermal medium using the laser irradiation mechanism ; capture an image including the chart using the camera ; and correct the irradiation parameter using the image. print a chart on the thermal medium using the laser irradiation mechanism ; capture an image including the chart using the camera ; and correct the irradiation parameter using the image.
An aqueous fixative solution for biological samples comprising: a) a C 2 to C 6 carboxylic acid at a concentration of 0.9M or greater; b) an alkaline earth halide salt at a concentration of 0.02M or greater; and c) a biocidal essential oil component in a concentration of at least 50μg/ml. a) a C 2 to C 6 carboxylic acid at a concentration of 0.9M or greater; b) an alkaline earth halide salt at a concentration of 0.02M or greater; and c) a biocidal essential oil component in a concentration of at least 50μg/ml.
A derailment sign detection system comprising: a detection section provided in a train and detecting a pitch angular velocity and a roll angular velocity of the train on traveling; a control device that makes a storage device store the roll angular velocity detected by the detection section , calculates a prediction value of the roll angular velocity after a lapse of a prediction time based on a history of the roll angular velocity, and determines that a derailment sign of the train is present in a case that the pitch angular velocity detected by the detection section and the prediction value of the roll angular velocity exceed preset threshold values respectively corresponding thereto; and an output section (A) that transmits the derailment sign to an outside in a case that the control device determines that the derailment sign is present, characterized in that : the control device calculates a change amount of the roll angular velocity in an inclination measurement time, and calculates the prediction value of the roll angular velocity after the lapse of the prediction time on an assumption that a change in the roll angular velocity is maintained after the lapse of the prediction time. a detection section provided in a train and detecting a pitch angular velocity and a roll angular velocity of the train on traveling; a control device that makes a storage device store the roll angular velocity detected by the detection section , calculates a prediction value of the roll angular velocity after a lapse of a prediction time based on a history of the roll angular velocity, and determines that a derailment sign of the train is present in a case that the pitch angular velocity detected by the detection section and the prediction value of the roll angular velocity exceed preset threshold values respectively corresponding thereto; and an output section (A) that transmits the derailment sign to an outside in a case that the control device determines that the derailment sign is present, characterized in that : the control device calculates a change amount of the roll angular velocity in an inclination measurement time, and calculates the prediction value of the roll angular velocity after the lapse of the prediction time on an assumption that a change in the roll angular velocity is maintained after the lapse of the prediction time.
A hearing protection system comprising - a communication unit ; - an ear canal microphone for provision of an ear canal input signal ; - a receiver for provision of an audio output signal based on an ear canal output signal , wherein the ear canal output signal is based on a first output signal from the communication unit ; - a compensation module for receiving and filtering the ear canal output signal for provision of a compensation signal ; and - a mixer connected to the ear canal microphone and the compensation module for provision of a voice signal based on the ear canal input signal and the compensation signal , wherein the compensation module comprises a filter controller , a primary filter and a secondary filter , wherein the primary filter is a static filter, wherein primary filter coefficients of the primary filter are static, and wherein the secondary filter is an adaptive filter, wherein secondary filter coefficients of the secondary filter are controlled by the filter controller based on the voice signal and a primary filter output signal from the primary filter , the filter controller having an input connected to the primary filter for receiving the primary filter output signal as an input to the filter controller . - a communication unit ; - an ear canal microphone for provision of an ear canal input signal ; - a receiver for provision of an audio output signal based on an ear canal output signal , wherein the ear canal output signal is based on a first output signal from the communication unit ; - a compensation module for receiving and filtering the ear canal output signal for provision of a compensation signal ; and - a mixer connected to the ear canal microphone and the compensation module for provision of a voice signal based on the ear canal input signal and the compensation signal ,
A multirotor aircraft that is adapted for vertical take-off and landing, comprising a fuselage , a thrust producing units assembly that is provided for producing thrust in operation, and a forward-swept wing that comprises a portside half wing and a starboard side half wing , each one of the portside and starboard side half wings comprising an inboard section that is connected to the fuselage and an outboard section that forms a wing tip , wherein the inboard sections of the portside and starboard side half wings form a central wing region , wherein each one of the portside and starboard side half wings is connected in the region of its wing tip to an associated outboard wing pod , wherein each one of the associated outboard wing pods supports at least two non-tiltably mounted thrust producing units of the thrust producing units assembly that are provided for generating lift at least during vertical taking-off and landing, wherein the associated outboard wing pod of the portside half wing is provided with a first and a second thrust producing unit , the first thrust producing unit being arranged near a trailing edge of the portside half wing and the second thrust producing unit being arranged near a leading edge of the portside half wing , wherein the associated outboard wing pod of the starboard side half wing is provided with a third and a fourth thrust producing unit , the third thrust producing unit being arranged near a trailing edge of the starboard side half wing and the fourth thrust producing unit being arranged near a leading edge of the starboard side half wing , wherein a thrust producing units sub-assembly of the thrust producing units assembly is provided in the central wing region near a trailing edge of the forward-swept wing for generating lift at least during vertical taking-off and landing, and characterised in that at least one thrust producing unit of the thrust producing units assembly is fixedly inclined with respect to a longitudinal axis of the multirotor aircraft for generating forward thrust at least during cruise operation of the multirotor aircraft .
An agent for use in the prophylaxis or improvement of frailty, comprising isoleucine and threonine as active ingredients, wherein the content of amino acids other than tryptophan, threonine, methionine and isoleucine is not more than 60 wt% of the amino acid contained, and wherein the frailty is at least one kind of symptom selected from the group consisting of loss of muscle mass, decline in grip strength, feeling of fatigue, depression state, delirium, dementia, sleep disorder, anxiety disorder and social withdrawal, in an elderly person.
A method of treating plants or plant parts with an antimicrobial agent comprising: placing one or more plants or plant parts in a chamber, sealing the chamber, adding a benzoxaborole compound to the chamber, adding a preservative gas to the chamber, wherein the benzoxaborole compound and the preservative gas combine to form an antimicrobial treatment, administering the antimicrobial treatment to the one or more plants or plant parts in the sealed chamber, and unsealing the chamber; wherein the preservative gas is CO 2 or SO 2 ; wherein when the preservative gas is CO 2 , the CO 2 concentration of the antimicrobial treatment ranges from about 4% to about 20%; and wherein when the preservative gas is SO 2 , the SO 2 concentration of the antimicrobial treatment ranges from about 0.001 % to about 1%; and wherein the benzoxaborole compound is Compound A having the structure: or Compound B having the structure: placing one or more plants or plant parts in a chamber, sealing the chamber, adding a benzoxaborole compound to the chamber, adding a preservative gas to the chamber, wherein the benzoxaborole compound and the preservative gas combine to form an antimicrobial treatment, administering the antimicrobial treatment to the one or more plants or plant parts in the sealed chamber, and unsealing the chamber; wherein the preservative gas is CO 2 or SO 2 ; wherein when the preservative gas is CO 2 , the CO 2 concentration of the antimicrobial treatment ranges from about 4% to about 20%; and wherein when the preservative gas is SO 2 , the SO 2 concentration of the antimicrobial treatment ranges from about 0.001 % to about 1%; and wherein the benzoxaborole compound is Compound A having the structure: or Compound B having the structure: Compound A having the structure: or Compound B having the structure:
A method for preventing or reducing low speed pre-ignition in a direct injected, boosted, spark ignited internal combustion engine, said method comprising the step of lubricating the crankcase of the engine with a lubricating oil composition comprising from 50 to 3000 ppm of metal from at least one zirconium-containing compound, based on the total weight of the lubricating oil composition.
A vaccine comprising non live Lawsonia intracellularis antigen and a pharmaceutically acceptable carrier for use in a method to reduce in a pig the shedding of Lawsonia intracellularis bacteria associated with a post vaccination subclinical infection with Lawsonia intracellularis, by systemic administration of the vaccine to the pig.
A wearable article comprising an elastic laminate, the elastic laminate comprising an inner nonwoven layer and an outer nonwoven layer, wherein the inner layer and the outer layer are directly joined with each other over an area of from about 5% to about 50% in that the inner layer and the outer layer are directly secured to each other by applying adhesive agents; the inner layer being closer to the body of the wearer than the outer layer when the article is worn, the inner layer having a first surface facing away from the outer layer and a second surface facing towards the outer layer, the outer layer having a higher hydrophilicity than the inner layer and having a first surface facing towards the inner layer and a second surface facing away from the inner layer, the inner layer being hydrophobic and the outer layer being hydrophilic; the laminate having a total caliper when subjected to the NMR MOUSE method as defined herein, the total caliper having a first sub-caliper corresponding to 50% of the total caliper starting from the outer layer's second surface and extending towards the inner layer's first surface, and a second sub-caliper corresponding to the remaining 50% of the total caliper starting from the inner layer's first surface and extending towards the outer layer's second surface, and wherein the elastic laminate has a Liquid Ratio of the first sub-caliper to the second sub-caliper of at least 1.1 after 1 minute according to the NMR MOUSE method set out herein; wherein, in the elastic laminate, the basis weight of the inner layer is not greater than the basis weight of the outer layer. the inner layer being closer to the body of the wearer than the outer layer when the article is worn, the inner layer having a first surface facing away from the outer layer and a second surface facing towards the outer layer, the outer layer having a higher hydrophilicity than the inner layer and having a first surface facing towards the inner layer and a second surface facing away from the inner layer, the inner layer being hydrophobic and the outer layer being hydrophilic; the laminate having a total caliper when subjected to the NMR MOUSE method as defined herein, the total caliper having a first sub-caliper corresponding to 50% of the total caliper starting from the outer layer's second surface and extending towards the inner layer's first surface, and a second sub-caliper corresponding to the remaining 50% of the total caliper starting from the inner layer's first surface and extending towards the outer layer's second surface, and wherein the elastic laminate has a Liquid Ratio of the first sub-caliper to the second sub-caliper of at least 1.1 after 1 minute according to the NMR MOUSE method set out herein; wherein, in the elastic laminate, the basis weight of the inner layer is not greater than the basis weight of the outer layer.
A process for the production of a functionalized, three-dimensional molding made of a composite in a mold, where the process comprises the following steps a) to d): e) insertion of the composite into the mold, where the composite comprises at least one fiber material, at least one compound V1 and at least one compound V2, and the temperature of the composite on insertion is in the range from 15 to 40°C, f) molding of the composite to give a three-dimensional molding in the mold, g) functionalization of the composite or of the three-dimensional molding via injection, onto the material, of at least one injection-molding polymer in the mold and h) removal of the functionalized, three-dimensional molding from the mold, wherein the compounds V1 and V2 harden to give a thermoset via crosslinking in the mold, and the temperature of the mold at least in the process steps a) and b) is mutually independently in the range from 80°C to 180°C, where i) process step c) is begun during implementation of process step b), or ii) process step c) is begun only after process step b) has ended. e) insertion of the composite into the mold, where the composite comprises at least one fiber material, at least one compound V1 and at least one compound V2, and the temperature of the composite on insertion is in the range from 15 to 40°C, f) molding of the composite to give a three-dimensional molding in the mold, g) functionalization of the composite or of the three-dimensional molding via injection, onto the material, of at least one injection-molding polymer in the mold and h) removal of the functionalized, three-dimensional molding from the mold, i) process step c) is begun during implementation of process step b), or ii) process step c) is begun only after process step b) has ended.